Location · Tennessee
Clinical trials recruiting in Tennessee
515 recruiting studies have at least one site in Tennessee; 118 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Tennessee.
515 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
ONL Therapeutics
- Location
- Nashville, TN + 55 other US sites
- Eligibility basics
- Ages 55+
- Recruiting
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Endologix
- Location
- Kingsport, TN + 24 other US sites
- Eligibility basics
- Ages 21+
- Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Inari Medical
- Location
- Nashville, TN + 32 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
BrioHealth Solutions, Inc.
- Location
- Memphis, TN + 46 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Takeda
- Location
- Jackson, TN + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
AbbVie
- Location
- Nashville, TN + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- Murfreesboro, TN + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice…
Eli Lilly and Company
- Location
- Smyrna, TN + 38 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Axsome Therapeutics, Inc.
- Location
- Knoxville, TN + 48 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Medtronic Cardiac Ablation Solutions
- Location
- Nashville, TN + 5 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
AstraZeneca
- Location
- Franklin, TN + 53 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Bristol-Myers Squibb
- Location
- Goodlettsville, TN + 26 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 1/Phase 2
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Ionis Pharmaceuticals, Inc.
- Location
- Memphis, TN + 4 other US sites
- Eligibility basics
- Ages 2–12
- RecruitingPhase 2
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Marea Therapeutics
- Location
- Memphis, TN + 6 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Inhibikase Therapeutics
- Location
- Nashville, TN + 14 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
Kuros Biosurgery AG
- Location
- Chattanooga, TN + 6 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and…
Novo Nordisk A/S
- Location
- Bristol, TN + 55 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 2/Phase 3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Merck Sharp & Dohme LLC
- Location
- Memphis, TN + 19 other US sites
- Eligibility basics
- Ages 1 mo–17
- RecruitingPhase 2/Phase 3
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Oculis
- Location
- Memphis, TN + 11 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Nipro Vascular Innovations Americas, Inc
- Location
- Tullahoma, TN + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
Locate Bio Pty Ltd
- Location
- Nashville, TN + 2 other US sites
- Eligibility basics
- Ages 22–80
- RecruitingPhase 3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Novartis Pharmaceuticals
- Location
- Knoxville, TN + 42 other US sites
- Eligibility basics
- Ages 40–70
- RecruitingPhase 2
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
Madrigal Pharmaceuticals, Inc.
- Location
- Nashville, TN + 11 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Chattanooga, TN + 54 other US sites
- Eligibility basics
- Ages 18–75